You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Details for Patent: 5,958,951


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,958,951
Title: Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
Abstract:The present invention provides R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride in its pure and stable anhydrous form.
Inventor(s): Ahrndt; Preben (.O slashed.lstykke, DK), Petersen; Henning B.o slashed.rge (Lyngby, DK), Chang; Vincent H. (Lake Forest, IL), Allen; Kimberly Ann (Silver Lake, WI), Cain; Michael H. (Grayslake, IL)
Assignee: Novo Nordiskials (Bagsvoerd, DK)
Application Number:08/872,380
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation; Composition; Use;
Patent landscape, scope, and claims:

United States Patent 5,958,951: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 5,958,951, granted on September 28, 1999, is a significant patent that warrants a thorough analysis to understand its scope, claims, and the broader patent landscape it operates within. This article will delve into the specifics of the patent, the importance of claim scope, and how it fits into the global patent system.

Patent Overview

Patent Number and Title

The patent in question is numbered 5,958,951. While the specific title of the patent is not provided in the sources, it is attributed to Ahrndt et al., indicating it is a collaborative invention.

Claim Scope and Importance

The claim scope of a patent is crucial for its validity and enforceability. As highlighted in patent law, the claim scope must be carefully crafted to avoid being too broad or too narrow. A broader claim scope, while desirable for broader protection, can be more difficult to get granted and easier to invalidate[3].

Claim Drafting Considerations

When drafting claims, patent practitioners must ensure that the claims are anchored to the embodiments disclosed in the specification. Overly broad claims can run afoul of the abstract idea exception, as seen in the Supreme Court's Alice decision. This exception prevents patents from effectively granting a monopoly over abstract ideas, which could stifle innovation[3].

The Abstract Idea Exception

Legal Framework

The abstract idea exception has been a significant factor in patent law since the Supreme Court's Alice decision. This decision shifted the legal framework dramatically, making it more challenging to secure broad claims that do not specify a particular means or method that improves the relevant technology. The Federal Circuit has consistently applied this principle, ensuring that claims do not preempt abstract ideas[3].

Case Examples

Cases like Yu v. Apple Inc. and Minerva Surgical, Inc. v. Hologic, Inc. illustrate the risks of overly broad claims. In Yu v. Apple Inc., the court concluded that the claim was directed to a result or effect that itself was an abstract idea, rather than a specific means or method. This highlights the need for precise and specific claim language to avoid invalidation[3].

Patent Searching and Prior Art

Importance of Prior Art

Before filing a patent application, it is essential to conduct a thorough search for prior art to ensure the invention is novel and non-obvious. The USPTO provides several tools for this purpose, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. This tool offers enhanced access to prior art and improves the overall patent searching process[1].

Global Dossier and International Searches

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices. This service is crucial for understanding the global patent landscape and ensuring that the invention is not already patented abroad. Other international databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), also offer valuable resources for searching prior art internationally[1][4].

Classification and Citation Data

Cooperative Patent Classification (CPC)

The Cooperative Patent Classification (CPC) database is a valuable resource for finding relevant classification schemes. This system helps in categorizing patents and applications, making it easier to identify prior art and related inventions[4].

Common Citation Document (CCD)

The Common Citation Document (CCD) application consolidates prior art cited by all participating offices for the family members of a patent application. This tool is part of the technical harmonization efforts at the international level, aimed at integrating the global patent system more effectively[1].

Patent Assignment and Examination Data

Patent Assignment Search

The Patent Assignment Search website allows users to search for patent assignments and changes in ownership. This is important for understanding the current ownership and any potential legal implications related to the patent[1].

Patent Examination Data System (PEDS)

The Patent Examination Data System (PEDS) provides public users with the ability to search, view, and download bibliographic data for all publicly available patent applications. This system is hosted in the Amazon Cloud and ensures secure access to this critical data[1].

The Role of Patent and Trademark Resource Centers (PTRCs)

Local Search Resources

PTRCs maintain local search resources and often offer training in patent search techniques. These centers are invaluable for inventors and patent practitioners who need assistance in conducting thorough patent searches and understanding the patent landscape[1][4].

Conclusion

Understanding the scope and claims of United States Patent 5,958,951 requires a deep dive into patent law, claim drafting strategies, and the global patent landscape. The importance of precise claim language, thorough prior art searches, and the use of advanced search tools cannot be overstated. By navigating these complexities, inventors and patent practitioners can ensure that their patents are robust, enforceable, and aligned with the evolving legal and technological landscape.

Key Takeaways

  • Claim Scope: The claim scope must be carefully balanced to avoid being too broad or too narrow.
  • Abstract Idea Exception: Claims must avoid preempting abstract ideas to avoid invalidation.
  • Prior Art Searches: Thorough searches using tools like Patent Public Search and Global Dossier are essential.
  • Classification and Citation Data: Tools like CPC and CCD help in categorizing and identifying related inventions.
  • Patent Assignment and Examination Data: Understanding ownership and examination data is crucial for legal and strategic purposes.
  • PTRCs: These centers provide valuable resources and training for patent searches.

FAQs

Q: What is the importance of claim scope in a patent application?

A: The claim scope is crucial as it defines the boundaries of the invention's protection. A balanced scope ensures the patent is enforceable and not easily invalidated.

Q: How does the abstract idea exception impact patent claims?

A: The abstract idea exception prevents claims from being too broad and preempting abstract ideas, ensuring that patents do not grant monopolies over general concepts.

Q: What tools are available for conducting prior art searches?

A: Tools like Patent Public Search, Global Dossier, and international databases from EPO, JPO, and WIPO are available for thorough prior art searches.

Q: What is the role of Cooperative Patent Classification (CPC) in patent searching?

A: CPC helps in categorizing patents and applications, making it easier to identify prior art and related inventions.

Q: How can Patent and Trademark Resource Centers (PTRCs) assist in patent searches?

A: PTRCs provide local search resources and training in patent search techniques, making them invaluable for inventors and patent practitioners.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. United States Patent 5,958,951: http://patentimages.storage.googleapis.com/pdfs/US5958951.pdf
  3. Rimon Law - The Importance of Getting the Claim Scope Right in a US Patent Application: https://www.rimonlaw.com/the-importance-of-getting-the-claim-scope-right-in-a-us-patent-application-i/
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 5,958,951

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 5,958,951

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0661/96Jun 14, 1996

International Family Members for US Patent 5,958,951

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 008236 ⤷  Try for Free
Australia 3165397 ⤷  Try for Free
Australia 723267 ⤷  Try for Free
Austria 223405 ⤷  Try for Free
Brazil 9709725 ⤷  Try for Free
Canada 2257931 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.